Overstitch Sx Endoscopic Suturing Systems News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Overstitch sx endoscopic suturing systems. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Overstitch Sx Endoscopic Suturing Systems Today - Breaking & Trending Today

Social Capital Suvretta Holdings Corp. I (NASDAQ:DNAA) and Apollo Endosurgery (NASDAQ:APEN) Critical Comparison

Social Capital Suvretta Holdings Corp. I (NASDAQ:DNAA – Get Rating) and Apollo Endosurgery (NASDAQ:APEN – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, earnings, profitability, institutional ownership and analyst recommendations. Analyst Ratings This is a […] ....

United States , Costa Rica , Apollo Endosurgery , Apollo Endosurgery Inc , Capital Suvretta Holdings Corp , Social Capital Suvretta Holdings , Get Rating , Given Apollo Endosurgery , Capital Suvretta Holdings , Overstitch Sx Endoscopic Suturing Systems , Orbera Intragastric Balloon System , Weight Loss System , X Tack Endoscopic Helix Tacking System , Social Capital Suvretta Holdings Corp I , Nasdaq Dnaa , Stock Comparison , Stock Analysis ,

Apollo Endosurgery (NASDAQ:APEN) Releases Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Apollo Endosurgery (NASDAQ:APEN – Get Rating) announced its quarterly earnings data on Tuesday. The biotechnology company reported ($0.21) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.01), MarketWatch Earnings reports. Apollo Endosurgery had a negative return on equity of 148.35% and a negative net margin of 39.19%. During the same […] ....

Stifel Nicolaus , Piper Sandler , Apollo Endosurgery , Geode Capital Management , Securities Exchange Commission , Apollo Endosurgery Inc , Goldman Sachs Group Inc , Zacks Investment Research , Blackrock Inc , Millennium Management , Get Rating , Marketwatch Earnings , Exchange Commission , Sachs Group , Capital Management , State Street Corp , Street Corp , Investment Research , Overstitch Sx Endoscopic Suturing Systems , Nasdaq Apen ,

Apollo Endosurgery (NASDAQ:APEN) Upgraded to Hold by Zacks Investment Research

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock. ....

United States , Costa Rica , Stifel Nicolaus , Asia Pacific , Piper Sandler , Apollo Endosurgery , Zacks Investment Research , Stonepine Capital Management , European Office , Blackrock Inc , Lpath Inc , Apollo Endosurgery Inc , Walleye Capital , Waypoint Capital Advisors , Get Rating , Intragastric Balloon System , Overstitch Endoscopic Suturing System , South America , Capital Advisors , Capital Management , Overstitch Sx Endoscopic Suturing Systems ,

Analysts Anticipate Apollo Endosurgery, Inc. (NASDAQ:APEN) to Post -$0.21 EPS

Wall Street brokerages forecast that Apollo Endosurgery, Inc. (NASDAQ:APEN – Get Rating) will post ($0.21) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for Apollo Endosurgery’s earnings. The lowest EPS estimate is ($0.27) and the highest is ($0.16). Apollo Endosurgery reported earnings per share of […] ....

Stifel Nicolaus , Piper Sandler , Apollo Endosurgery , Securities Exchange Commission , Zacks Investment Research , Stonepine Capital Management , Blackrock Inc , Apollo Endosurgery Inc , Walleye Capital , Waypoint Capital Advisors , Wall Street , Get Rating , Investment Research , Exchange Commission , Capital Advisors , Capital Management , Overstitch Sx Endoscopic Suturing Systems , Nasdaq Apen ,

Apollo Endosurgery, Inc. (NASDAQ:APEN) Expected to Announce Quarterly Sales of $15.69 Million

Equities analysts predict that Apollo Endosurgery, Inc. (NASDAQ:APEN – Get Rating) will report $15.69 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for Apollo Endosurgery’s earnings, with the highest sales estimate coming in at $15.90 million and the lowest estimate coming in at $15.49 million. Apollo […] ....

United States , Stifel Nicolaus , Piper Sandler , Apollo Endosurgery , Jpmorgan Chase Co , Apollo Endosurgery Inc , Zacks Investment Research , America Corp , Barclays Plc , Lazard Asset Management , Get Rating , Investment Research , Asset Management , Trexquant Investment , Overstitch Sx Endoscopic Suturing Systems , Nasdaq Apen ,